Rijksinstituut voor Volksgezondheid en Milieu
Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study | RIVM
Bron:
rivm.nl